Generic ICD programming and outcomes
Autor: | Nishat Jahagirdar, Edward Petzer, Antonio Cannatà, Paul A. Scott, Micaela Laybourn, Idris Harding, Parisha Khan, Husain Shabeeh, Francis Murgatroyd, Daniel I. Bromage, Peter Kabunga |
---|---|
Rok vydání: | 2021 |
Předmět: |
Male
medicine.medical_specialty medicine.medical_treatment Single Center Ventricular tachycardia Prosthesis Design law.invention Randomized controlled trial law Internal medicine medicine Secondary Prevention Humans Protocol (object-oriented programming) Survival analysis Aged Retrospective Studies business.industry Retrospective cohort study General Medicine Guideline Middle Aged Implantable cardioverter-defibrillator medicine.disease Defibrillators Implantable Primary Prevention Female Guideline Adherence Cardiology and Cardiovascular Medicine business Algorithms |
Zdroj: | Pacing and clinical electrophysiology : PACEREFERENCES. 44(12) |
ISSN: | 1540-8159 |
Popis: | INTRODUCTION Generic ICD programming, where shock-reduction programming is extrapolated from trials of one manufacturer to another, may reduce non-essential ICD therapies beyond that seen in randomized trials. However, the benefits and risks are unknown. The purpose of this retrospective cohort study was to evaluate the impact of a standardized programming protocol, based on generic programming, across manufacturers. METHODS We included all new ICDs in a single center (2009-2019). In 2013 a standardized programming protocol based on generic programming was introduced, incorporating high detection rates (200 bpm for primary prevention) and long detection (30/40 or equivalent in VF zone) for all patients. Patients were classified into three groups based on implant programming: pre-guideline (PS), post-guideline and guideline compliant (GC) and post-guideline but not guideline compliant (NGC). The end-points were the first occurrence of any device therapy (ATP or shock), ICD shock, syncope and all-cause mortality. Survival analysis was used to evaluate outcomes. RESULTS 1003 patients were included (mean follow-up 1519 ± 1005 days). In primary prevention patients (n = 583) freedom from ICD therapy (91.5% vs. 73.6%, p |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |